Home › Drug Codes › J Codes › J0741 · CABENUVA
Updated July 1st, 2026

CABENUVA J Code: J0741

Injection, cabotegravir and rilpivirine, 2mg/3mg

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J0741, effective October 1, 2026: $24.649 per HCPCS billing unit, down 0.1% from $24.667. From CMS's final file.

?
Medicare Payment Limit ?
$24.667
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
$24.667
/ HCPCS billing unit · APC 9414
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
2
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, cabotegravir and rilpivirine, 2mg/3mg
HCPCS Added Date October 1, 2021
Manufacturer ViiV
Route of Administration Intramuscular
Generic Status Single-Source; Branded
Dosage Type Single-Dose
Dosage Form Kit

About CABENUVA

Cabenuva is a medication aligned to the HCPCS J Code: J0741 for billing, pricing, and reimbursement purposes in the United States. This Anti-HIV medication is administered via the intramuscular route and manufactured by ViiV.

According to CMS Drug Use Information: This product is used to help control HIV infection. It contains 2 medications: cabotegravir and rilpivirine. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Cabotegravir is an integrase inhibitor while rilpivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). Both drugs block the virus from growing and infecting more cells. Cabotegravir/rilpivirine is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
49702-0240-15 Cabenuva ViiV Healthcare Company 300 Kit
49702-0253-15 Cabenuva ViiV Healthcare Company 200 Kit
Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

CABENUVA Pricing & Reimbursement

J0741 Private Payer Reimbursement
$24.12 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

CABENUVA Claims Performance

Claims from Jan 2026 – Aug 2026
Claim Denial Rate 26.69%
Avg. Days to File 7.9days
Avg. Days to Pay 24.7days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J0741 claims analytics on FocalPoint →
OnPoint Oncology

CABENUVA CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96372 Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intramuscular
JW / JZ modifiers apply

CMS has identified Cabenuva (J0741) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

CABENUVA Medically Unlikely Edits (MUE)

The most billing units of J0741 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 2 mg - 3 mg.

Practitioner Office & Hospital Outpatient
300 units / day
= 600 mg - 3 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg - 3 mg Enter a dose to see how many billing units it is and whether it is under the limit.

CABENUVA Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

HIV-1 infection

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.
Access Full Report →

Frequently Asked Questions

Is there an available Cabenuva billing and coding guide?
Billing and coding information for CABENUVA can be found through ViiV. Visit Here →
Are there any available Cabenuva patient assistance programs?
CABENUVA patient assistance information can be found through ViiV. Visit Here →
Where can I find Cabenuva prescribing information?
CABENUVA prescribing information can be found at the link below: Visit Here →
Where can I find Cabenuva side effect information?
Information regarding CABENUVA's side effects can be found at MedlinePlus Visit Here →
Does billing CABENUVA require JZ/JW wastage modifiers?
CMS has identified CABENUVA(J0741) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.

Related Drug Codes

Explore billing, coding, and pricing for drugs related to CABENUVA.

J0738YEZTUGOInjection, lenacapavir, 1 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)Gilead Sciences, IncAdded October 1, 2025J0739APRETUDEInjection, cabotegravir, 1mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)ViiVAdded July 1, 2022J0750TRUVADAEmtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)Multiple ManufacturersAdded January 2, 2024J0751TRUVADAEmtricitabine 200mg and tenofovir alafenamide 25mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)Gilead Sciences, IncAdded January 2, 2024J0752YEZTUGOOral, lenacapavir, 300 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)Gilead Sciences, IncAdded October 1, 2025J0799Not Otherwise ClassifiedFda approved prescription drug, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv), not otherwise classifiedAdded January 2, 2024J1324FUZEONInjection, enfuvirtide, 1 mgGenentechAdded January 1, 2007J1746TROGARZOInjection, ibalizumab-uiyk, 10 mgTheratechnologiesAdded January 1, 2019J2860SYLVANTInjection, siltuximab, 10 mgRecordati Rare DiseasesAdded January 1, 2016J3485RETROVIRInjection, zidovudine, 10 mgViiVAdded January 1, 2001